Cytogenetic and molecular-genetic characteristics in peripheral T cell lymphoma (PTL) have not been well defined, except for those in adult T cell leukemia/lymphoma (ATL/L). Translocations and inversions involving a chromosome band 14q32 were extremely common abnormalities reported in PTL and ATL/L. We studied the involvement of TCL1, a recently isolated gene located in 14q32.1, in tumor tissues from 20 patients with PTL including three with 14q32 translocations by two color fluorescent in situ hybridization (FISH) using two cosmid probes flanking the TCL1 gene. The two cosmid signals were separated in none of them, but much increased in number in one tumor without 14q32 translocation, indicating that the TCL1 genomic region was amplified in this tumor. Reverse transcription-polymerase chain reaction (RT-PCR), however, failed to detect the TCL1 transcript in the tumor. These findings suggest that an oncogene other than TCL1 may be located in 14q32.1, and its amplification may be involved in the neoplastic process of PTL.
Introduction
TCL1 was isolated from the 14q32.1 chromosomal region where the breakpoints of 14q32 translocations associated with T cell neoplasms were clustered. 1, 2 In our chromosome study of 60 patients with peripheral T cell lymphoma (PTL) and a karyotype review committee report on ATL/L, translocations and inversions involving chromosome 14q32 were extremely common abnormalities among rather rare chromosomal exchanges. 3, 4 These findings suggest that TCL1 is a candidate oncogene that is involved in the genesis of T cell neoplasms including PTL. In the present study of 20 cases of PTL by twocolor FISH using TCL1 probes, we found one case which has amplification of the TCL1 flanking region at 14q32.1 with no TCL1 gene transcription.
Case report
A 78-year-old man (No. 916550) was referred to us with a gastric tumor, and enlarged cervical and para-aortic lymph nodes. Histologic examination of biopsy specimens taken from the gastric tumor and the cervical lymph node showed PTL, unspecified. 5 The patient failed to respond to chemotherapy, and died 16 months after the diagnosis. 
Results and discussion
The involvement of TCL1 was evaluated in tumor tissue from this patient and the other 19 patients with PTL, including three with 14q32 translocations, by two-color FISH. We used two cosmid clones, pPLC-1 and pPLC-4, which are located in a chromosome band 14q32.1 and about 250 kb apart, and flank the TCL1 genomic locus. 2 The two (red and green) cosmid signals were not separated and appeared to be almost overlapping each other in all the 20 tumors. Two copies of the combined signals were seen in each lymphoma cell from 19 patients, but multiple copies of the combined signal were found in lymphoma cells with tetraploidy and no apparent 14q32 translocations from the patient (No. 916550) (Figure 1) . The results indicate that the TCL1 locus did not split in all 20 tumors, and suggest that TCL1 was not rearranged by chromosome translocations or other cytogenetic abnormalities in our PTL patients. The results also indicate that the TCL1 genomic region was amplified in one of the 20 tumors.
Southern blotting analysis, using TCL1 cDNA probe, showed a single copy of TCL1 in tumor tissues from all the three PLT patients including one (No. 916550) with multiple copies of the combined cosmid signal. We suspect that the existence of normal lymphocytes in the lymphoma tissue obscured the amplification in the lymphoma cells of the patient (No. 916550).
Presence or absence of the TCL1 transcript was evaluated in lymphoma cells from patient No. 916550, peripheral mononuclear cells from one healthy individual, and lymphoblasts from the Daudi cell line using the reverse-transcriptionpolymerase chain reaction (RT-PCR) with TCL1 primers 170S (5Ј-AGGATAGGTTACAGTTACGGGTGC-3Ј) and 386AS (5Ј-GTGCTGCCAAGACCATACATCAGT-3Ј). For the control amplification, AML1 primers AML1-C and AML1-E were used as previously described. 6 As shown in Figure 2 , the TCL1 transcript was detected in the Daudi cell line, but not in the lymphoma cells from the patient and the control mononuclear cells. Presence of the AML1 transcript in the three samples, which was amplified from the same amount of cDNA template used for TCL1 amplification, showed that all mRNA samples were intact.
The amplification of the TCL1 genomic region detected by FISH, but no expression of the TCL1 mRNA suggest the presence of an oncogene other than TCL1 in the TCL1 genomic region which may have been amplified and participate in the neoplastic process of PTL in this patient. The TCL1 genomic region may be a good target for the molecular cloning of oncogenes, which are causally involved in the development and progression of PTL. 
Figure 2
Agarose-gel electrophoresis analysis of PCR products stained with ethidium bromide from patient No. 916550, Daudi cell line, and a healthy individual. While the 192 bp transcript of AML1 was detected in all three samples, the 240 bp transcript of TCL1 was detected only in the Daudi cell line.
